METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination

• Ngā kaituhi matua: Danyang Shen (Author), Lifeng Ding (Author), Zeyi Lu (Author), Ruyue Wang (Author), Chenhao Yu (Author), Huan Wang (Author), Qiming Zheng (Author), Xuliang Wang (Author), Wanjiang Xu (Author), Haifeng Yu (Author), Liwei Xu (Author), Mingchao Wang (Author), Shicheng Yu (Author), Shibin Zhu (Author), Jun Qian (Author), Liqun Xia (Author), Gonghui Li (Author)
• Hōputu: Pukapuka
• I whakaputaina: Elsevier, 2022-03-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Clear cell renal cell carcinoma (ccRCC) is the most lethal urological cancer and is characterized by a high rate of metastasis and relapse. N6-Methyladenosine (m6A) is implicated in various stages of cancer development. However, a thorough understanding of m6A-modified lncRNAs in ccRCC is lacking. T...